Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results

FY2025 sales rose 29.3% to €7.17 million; total value of production increased 34.7% to €8.47 million EBITDA grew 68.1% to €1.61 million, expanding the EBITDA margin by approximately 380 basis points to 19.0% Operating profit advanced 80.8% to €1.21 million

MILAN, July 22, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), evolving into Saentra Forge 1 , a strategic industrial consolidator focused on aerospace, defense, biotech and Italian national-security-related technologies, today announced that the Board of Directors of Sòphia High Tech S.r.l. (“Sòphia HT”) has approved the company’s financial statements for the fiscal year ended December 31, 2025.

These financial statements were approved by Sòphia HT’s Board of Directors.

The following table summarizes Sòphia HT’s key results for the fiscal year ended December 31, 2025, compared with the prior fiscal year:

FY2025FY2024ChangeSales7.175.54+29.3%Other operating income1.300.75+73.3%Total value of production8.476.29+34.7%EBITDA1.610.96+68.1%EBITDA margin19.0%15.2%+380 bpsOperating profit1.210.67+80.8%

Figures in € millions unless otherwise stated and reflect the financial statements approved by Sòphia HT’s Board of Directors, which remain subject to approval by the shareholders’ meeting.

EBITDA and EBITDA margin are non-GAAP measures; see “Non-GAAP Information” and “Important Information Regarding Sòphia HT Financial Data.” Percentage changes reflect figures reported by Sòphia HT and may be affected by rounding.

Genenta-backed Sòphia HT delivered broad-based growth across both its top line and profitability in FY2025.

The performance reflected higher sales, increased other operating income and a more disciplined cost structure, which together drove margin expansion and a marked improvement in operating profitability.

Sòphia HT has also appointed a new Board of Directors to guide its next phase of growth in the Aerospace & Defense market.

The new governance pairs the founders' engineering leadership — Antonio Caraviello (CEO & Chairman), Raffaele Sansone (COO) and Domenico Borrelli (CTO) — with the financial and industrial expertise brought by Genenta Science S.p.A. (Nasdaq: GNTA) represented on the Board by Pierluigi Paracchi and Gianfranco de Nigris , with Paolo Salvato as Board Observer.

This shared executive leadership will drive Sòphia HT's industrial scale-up and international expansion.

Important Information Regarding Sòphia HT Financial Data The financial information relating to Sòphia HT included in this press release was prepared by, and is the responsibility of, the management of Sòphia HT and is derived from Sòphia HT’s statutory financial statements prepared in accordance with Italian accounting principles.

Such financial information is unaudited, and has not been independently verified, audited, or reviewed by Genenta Science S.p.A. (“Genenta”) or by Genenta’s independent registered public accounting firm.

In addition, such information is not presented in accordance with U.S. GAAP or IFRS Accounting Standards as adopted by the European Union and has not been consolidated into Genenta’s financial statements.

Genenta currently owns approximately 19% of Sòphia HT and does not currently consolidate Sòphia HT’s financial results.

Although Genenta has contractual rights, subject to the applicable terms and conditions, to increase its ownership interest to 51%, there can be no assurance that such rights will be exercised or that Sòphia HT will become a consolidated subsidiary of Genenta.

The financial information presented herein was provided to Gene...